Katja A. Puttonen

Ferring Pharmaceuticals (Switzerland) — Switzerland

Biochemistry, Genetics and Molecular Biology · Life Sciences

20h-index1.5kcitations40works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pluripotent Stem Cells Research(9), Cell death mechanisms and regulation(6), Peptidase Inhibition and Analysis(6), Alzheimer's disease research and treatments(4), RNA Interference and Gene Delivery(4)

Publications40 total

Transcriptomic characterization of GMP-compliant regulatory macrophages (TRI-001) under inflammatory and hypoxic conditions: a comparative analysis across macrophage subtypes
Journal of Translational Medicine·2025· 1 citedOpen Access
Cytokines impact natural killer cell phenotype and functionality against glioblastoma in vitro
Frontiers in Immunology·2023· 11 citedOpen Access
Metabolic alterations in Parkinson’s disease astrocytes
Scientific Reports·2020· 167 citedOpen Access
Transcriptomics uncovers substantial variability associated with alterations in manufacturing processes of macrophage cell therapy products
Scientific Reports·2020· 37 citedOpen Access
Translation of small-scale CAR-T cell manufacturing methods to a clinical-scale production platform
Cytotherapy·2020· 1 cited
Neurobiological roots of psychopathy
STM:n Hallinnonalan avoin julkaisuarkisto (Julkari)·2020
Neurobiological roots of psychopathy (vol 25, pg 3432, 2020)
WOS·2020
Correction: Neurobiological roots of psychopathy
Molecular Psychiatry·2019Open Access
Sex-specific transcriptional and proteomic signatures in schizophrenia
Nature Communications·2019· 66 citedOpen Access
Neurobiological roots of psychopathy
Molecular Psychiatry·2019· 42 citedOpen Access
O7.7. NEUROBIOLOGICAL ROOTS OF SCHIZOPHRENIA
Schizophrenia Bulletin·2019Open Access
NEUROBIOLOGICAL ROOTS OF SCHIZOPHRENIA
STM:n Hallinnonalan avoin julkaisuarkisto (Julkari)·2019
Generation of a human induced pluripotent stem cell line (LL008 1.4) from a familial Alzheimer's disease patient carrying a double KM670/671NL (Swedish) mutation in APP gene
Stem Cell Research·2018· 11 citedOpen Access
Human iPSC-derived neurons and astrocytes as models of neurodegeneration, neuroinflammation and vesicular trafficking in Alzheimer's disease
Free Radical Biology and Medicine·2018· 2 cited
Temporal Dynamics of Gene Expression During Endothelial Cell Differentiation From Human iPS Cells: A Comparison Study of Signalling Factors and Small Molecules
Frontiers in Cardiovascular Medicine·2018· 14 citedOpen Access
Structural Immaturity of Human iPSC-Derived Cardiomyocytes: In Silico Investigation of Effects on Function and Disease Modeling
Frontiers in Physiology·2018· 166 citedOpen Access
Identification of mechanisms leading to blood-brain barrier dysfunction in Parkinson's disease
Proceedings for Annual Meeting of The Japanese Pharmacological Society·2018Open Access
PSEN1 Mutant iPSC-Derived Model Reveals Severe Astrocyte Pathology in Alzheimer's Disease
Stem Cell Reports·2017· 329 citedOpen Access
[P3–170]: HUMAN IPSC‐DERIVED ALZHEIMER's DISEASE ASTROCYTES RECAPITULATE DISEASE‐RELATED PHENOTYPES
Alzheimer s & Dementia·2017
Creation of a library of induced pluripotent stem cells from Parkinsonian patients
npj Parkinson s Disease·2016· 91 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Jari Koıstınaho(21), Šárka Lehtonen(18), Minna Oksanen(9), Marja Koskuvi(9), Pekka T. Männistö(9), Ida Hyötyläinen(8), Jari Tiihonen(7), Yanyan Gao(7), Ilkka Ojansuu(7), Olli Vaurio(7), Markku Lähteenvuo(7), Atso Raasmaja(7), Pasi Tavi(6), Marika Ruponen(6), Markus Storvik(6), Nikolay Naumenko(5), Riikka H. Hämäläinen(5), Tuija Kekarainen(5), Anastasia Shakirzyanova(4), Rashid Giniatullin(4)